David Roblin

Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D
Endpoints
Thu, 06/9/22 - 10:46 am
Pfizer
David Roblin
machine learning
funding
gemonics
R&D
Relation Therapeutics